This highlights the paradoxical role of NF-kB, where its activation due to intermediate levels of ROS generated during lower dosages of therapeutic strategies inducing oxidative stress (e.g., radiotherapy and PDT), enhances tumor cell growth and on the other hand activates the antitumoral immunity. Here, NFKB1 is linked to neoplasm.